SCHEMBL23959153

SCHEMBL23959153

c1ccc(-c2nc3nc(-n4c5ccccc5c5cc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)ccc54)ccn3c2-c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 11/20 0.41
▸ AKT2 P31751 10/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ ROCK2 O75116 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ NPY5R Q15761 1/20 0.35
▸ IL1R1 P14778 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ MAPK13 O15264 1/20 0.34
▸ MAPK12 P53778 1/20 0.34
▸ MAPK11 Q15759 1/20 0.34
▸ MAPK14 Q16539 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959313 0.91 AKT1 (0.40) AKT1AKT2L3MBTL1KDM4EATM
SCHEMBL23959315 0.91 AKT1 (0.44) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959155 0.90 AKT1 (0.41) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959241 0.89 AKT1 (0.45) AKT1AKT2L3MBTL1ROCK2PIM1
SCHEMBL23959317 0.88 AKT1 (0.50) AKT1AKT2L3MBTL1KDM4EATM
SCHEMBL23959316 0.84 AKT1 (0.40) AKT1AKT2L3MBTL1KDM4EATM
SCHEMBL17658813 0.84 ROCK2 (0.53) AKT1AKT2L3MBTL1KDM4EATM
SCHEMBL17658822 0.84 ROCK2 (0.53) AKT1AKT2L3MBTL1KDM4EATM
SCHEMBL17658812 0.84 ROCK2 (0.53) AKT1AKT2L3MBTL1KDM4EATM
SCHEMBL17658823 0.84 ROCK2 (0.53) AKT1AKT2L3MBTL1KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-12-07 — — US disclosed
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885L3MBTL1 384/4885
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885L3MBTL1 384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback